Skip to main content
Year archive

IMUGENE LIMITED — 2021 filings

All 150 regulatory filings released by IMUGENE LIMITED (IMU) in 2021, sourced directly from the official regulator.

150 Filings
2021 Period
2021 filings (150)
Filing Released Lang
Application for quotation of securities - IMU 8 pages 32.3KB
Share Issue/Capital Change
2021-12-22 English
Notification regarding unquoted securities - IMU 9 pages 32.2KB
Share Issue/Capital Change
2021-12-22 English
Notice Under Section 708A 1 page 165.6KB
Capital/Financing Update
2021-12-22 English
Appendix 2A and IMUOB Option Underwriting Agreement 21 pages 442.4KB
Capital/Financing Update
2021-12-19 English
Change of Director's Interest Notice - CW 4 pages 274.8KB
Director's Dealing
2021-12-19 English
Change in substantial holding - PH 3 pages 220.1KB
Major Shareholding Notification
2021-12-14 English
Imugene HER-Vaxx Immunotherapy Patent Allowed in China 2 pages 151.7KB
Regulatory Filings
2021-12-13 English
FDA IND APPROVAL FOR ONCOLYTIC VIROTHERAPY VAXINIA 3 pages 131.8KB
Regulatory Filings
2021-12-12 English
FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX 3 pages 186.4KB
Regulatory Filings
2021-12-12 English
Change of Director's Interest Notice - PH 5 pages 306.4KB
Director's Dealing
2021-12-12 English
Appendix 2A 20 pages 376.4KB
Capital/Financing Update
2021-12-09 English
Change in Joint Company Secretary 1 page 98.2KB
Board/Management Information
2021-12-07 English
Update on Clinical Trial of Oncolytic Virotherapy CHECKvacc 5 pages 163.7KB
Regulatory Filings
2021-12-06 English
Appendix 2A 20 pages 375.8KB
Regulatory Filings
2021-12-05 English
Appendix 2A 20 pages 376.0KB
Capital/Financing Update
2021-11-25 English
Results of Meeting Percentages 2 pages 158.1KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-22 English
Change of Director's Interest Notice (AH) 3 pages 178.4KB
Director's Dealing
2021-11-21 English
Ceasing to be a Director 2 pages 81.8KB
Board/Management Information
2021-11-21 English
Final Director's Interest Notice (AH) 2 pages 268.4KB
Director's Dealing
2021-11-21 English
AGM Presentation 11 pages 4.9MB
AGM Information
2021-11-18 English
Application for quotation of securities - IMU 9 pages 32.3KB
Share Issue/Capital Change
2021-11-18 English
Results of Meeting 2 pages 521.3KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-18 English
Clinical Trial Supply Agreement with Merck KGaA and Pfizer 2 pages 123.9KB
Regulatory Filings
2021-11-15 English
Application for quotation of securities - IMU 8 pages 30.0KB
Share Issue/Capital Change
2021-11-15 English
Notice Under Section 708A 1 page 167.3KB
Capital/Financing Update
2021-11-15 English
Application for quotation of securities - IMU 9 pages 32.4KB
Share Issue/Capital Change
2021-11-11 English
Eureka Strategic Collaboration (supplementary announcement) 3 pages 126.4KB
Capital/Financing Update
2021-11-08 English
Application for quotation of securities - IMU 9 pages 32.3KB
Share Issue/Capital Change
2021-11-04 English
Imugene and Eureka Therapeutics onCARlytics Collaboration 3 pages 143.7KB
Regulatory Filings
2021-10-31 English
Investor webinar Imugene & Eureka Therapeutics Collaboration 2 pages 113.9KB
Regulatory Filings
2021-10-31 English
Investor Presentation Imugene Eureka Therapeutics 18 pages 2.3MB
Investor Presentation
2021-10-31 English
Application for quotation of securities - IMU 9 pages 32.3KB
Share Issue/Capital Change
2021-10-28 English
Letter to IMUOB Optionholders 3 pages 902.1KB
Capital/Financing Update
2021-10-24 English
Application for quotation of securities - IMU 9 pages 32.4KB
Share Issue/Capital Change
2021-10-24 English
Quarterly Activities/Appendix 4C Cash Flow Report 13 pages 3.3MB
Interim / Quarterly Report
2021-10-21 English
Application for quotation of securities - IMU 8 pages 27.1KB
Share Issue/Capital Change
2021-10-21 English
Notice Under Section 708A 1 page 158.6KB
Capital/Financing Update
2021-10-21 English
Change of Director's Interest Notice - PH 3 pages 173.2KB
Director's Dealing
2021-10-21 English
Change in substantial holding - PH 3 pages 185.4KB
Major Shareholding Notification
2021-10-21 English
FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF CHECKVACC 5 pages 103.6KB
Regulatory Filings
2021-10-19 English
Proposed issue of securities - IMU 5 pages 27.5KB
Capital/Financing Update
2021-10-19 English
Application for quotation of securities - IMU 9 pages 32.3KB
Capital/Financing Update
2021-10-14 English
Notice of Annual General Meeting/Proxy Form 14 pages 975.1KB
AGM Information
2021-10-13 English
Change of Director's Interest Notice - LR 2 pages 240.1KB
Director's Dealing
2021-10-10 English
Application for quotation of securities - IMU 9 pages 32.3KB
Share Issue/Capital Change
2021-10-07 English
Investor Presentation 31 pages 5.1MB
Investor Presentation
2021-10-04 English
Annual Report to shareholders 97 pages 9.3MB
Regulatory Filings
2021-10-03 English
Appendix 4G 12 pages 291.5KB
Regulatory Filings
2021-10-03 English
Corporate Governance Statement 7 pages 214.5KB
Governance Information
2021-10-03 English
Application for quotation of securities - IMU 9 pages 32.4KB
Share Issue/Capital Change
2021-09-30 English
Imugene HER-Vaxx Immunotherapy Patent Granted in Japan 2 pages 150.3KB
Regulatory Filings
2021-09-21 English
PD1-Vaxx Presentation at ESMO Congress 2021 Annual Meeting 2 pages 131.6KB
Investor Presentation
2021-09-16 English
Application for quotation of securities - IMU 9 pages 32.4KB
Share Issue/Capital Change
2021-09-16 English
Change of Director's Interest Notice - PH 3 pages 181.6KB
Director's Dealing
2021-09-12 English
Becoming a substantial holder - PH 3 pages 162.1KB
Major Shareholding Notification
2021-09-12 English
Application for quotation of securities - IMU 10 pages 36.1KB
Share Issue/Capital Change
2021-09-12 English
Application for quotation of securities - IMU 8 pages 30.1KB
Share Issue/Capital Change
2021-09-08 English
Results of Meeting 2 pages 136.3KB
Declaration of Voting Results & Voting Rights Announcements
2021-09-06 English
Proposed issue of securities - IMU 5 pages 28.0KB
Capital/Financing Update
2021-09-06 English
Application for quotation of securities - IMU 9 pages 32.3KB
Share Issue/Capital Change
2021-09-02 English
Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials 3 pages 157.8KB
Capital/Financing Update
2021-08-31 English
Appendix 4E and Full Year Statutory Accounts 86 pages 2.0MB
Annual Report
2021-08-29 English
Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx 2 pages 147.4KB
Regulatory Filings
2021-08-26 English
Application for quotation of securities - IMU 9 pages 32.4KB
Share Issue/Capital Change
2021-08-26 English
Response to ASX Query 4 pages 251.4KB
Regulatory Filings
2021-08-22 English
Appendix 2A 20 pages 441.5KB
Share Issue/Capital Change
2021-08-19 English
Results of Share Purchase Plan 2 pages 146.4KB
Capital/Financing Update
2021-08-18 English
Application for quotation of securities - IMU 8 pages 31.5KB
Share Issue/Capital Change
2021-08-12 English
Further Information on Partnership with Celularity 2 pages 126.1KB
Regulatory Filings
2021-08-09 English
Notice of Extraordinary General Meeting/Proxy Form 23 pages 492.0KB
Proxy Solicitation & Information Statement
2021-08-05 English
Research partnership with Celularity for solid tumors 5 pages 215.7KB
Regulatory Filings
2021-08-04 English
Investor Presentation 18 pages 1.7MB
Investor Presentation
2021-08-04 English
Imugene Investor Webinar with Celularity Dr Robert Hariri 1
Regulatory Filings
2021-08-04 English
Application for quotation of securities - IMU 7 pages 28.7KB
Share Issue/Capital Change
2021-08-03 English
Notice Under Section 708A 1 page 159.4KB
Capital/Financing Update
2021-08-03 English
Imugene to present at NWR virtual investor conference 1
Regulatory Filings
2021-08-01 English
Imugene completes $90 M placement and launches $5 M SPP 4 pages 176.8KB
Capital/Financing Update
2021-07-28 English
Imugene Capital Raising Presentation 28 pages 3.2MB
Capital/Financing Update
2021-07-28 English
Proposed issue of securities - IMU 6 pages 31.3KB
Capital/Financing Update
2021-07-28 English
Proposed issue of securities - IMU 8 pages 35.8KB
Capital/Financing Update
2021-07-28 English
Prospectus for SPP and Placement Options Offer 50 pages 479.3KB
Capital/Financing Update
2021-07-28 English
Investor Webinar 1 page 122.2KB
Capital/Financing Update
2021-07-27 English
Trading Halt 2 pages 185.3KB
Capital/Financing Update
2021-07-26 English
Application for quotation of securities - IMU 8 pages 31.5KB
Share Issue/Capital Change
2021-07-25 English
Appendix 4C - Quarterly Report 10 pages 365.7KB
Interim / Quarterly Report
2021-07-22 English
Issuance of Milestone Shares Under Vaxinia Acquisition 3 pages 148.5KB
Capital/Financing Update
2021-07-08 English
Proposed issue of securities - IMU 5 pages 28.2KB
Capital/Financing Update
2021-07-08 English
Appendix 2A 19 pages 359.6KB
Capital/Financing Update
2021-07-08 English
Application for quotation of securities - IMU 8 pages 31.5KB
Share Issue/Capital Change
2021-07-08 English
Notice Under Section 708A 1 page 159.3KB
Capital/Financing Update
2021-07-08 English
Imugene Presents HER-Vaxx Update at ESMO World GI Congress 3 pages 174.7KB
Investor Presentation
2021-07-04 English
Change of Director's Interest Notice - LR 3 pages 255.3KB
Director's Dealing
2021-07-04 English
FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC 5 pages 133.2KB
Regulatory Filings
2021-07-01 English
Application for quotation of securities - IMU 9 pages 33.7KB
Share Issue/Capital Change
2021-06-28 English
Application for quotation of securities - IMU 8 pages 31.5KB
Share Issue/Capital Change
2021-06-24 English
Notification regarding unquoted securities - IMU 7 pages 30.8KB
Share Issue/Capital Change
2021-06-14 English
Application for quotation of securities - IMU 7 pages 30.1KB
Capital/Financing Update
2021-06-14 English
Notice Under Section 708A 1 page 159.9KB
Regulatory Filings
2021-06-14 English
Investor Webinar Presentation 2 pages 148.2KB
Investor Presentation
2021-06-10 English
Investor Webinar Presentation Clarification 2 pages 146.9KB
Regulatory Filings
2021-06-10 English
Investor Presentation 25 pages 3.3MB
Investor Presentation
2021-06-10 English
Proposed issue of securities - IMU 7 pages 31.8KB
Capital/Financing Update
2021-06-10 English
Imugene Appoints Dr Monil Shah as Chief Business Officer 2 pages 151.3KB
Board/Management Information
2021-06-09 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2021-06-03 English
Appendix 2A 15 pages 394.4KB
Regulatory Filings
2021-06-03 English
Managing Director and CEO increases shareholding in Imugene 2 pages 164.9KB
Director's Dealing
2021-05-27 English
Proposed issue of Securities - IMU 6 pages 29.9KB
Capital/Financing Update
2021-05-27 English
Appendix 2A 15 pages 387.9KB
Capital/Financing Update
2021-05-27 English
Change of Director's Interest Notice - LC 3 pages 179.9KB
Director's Dealing
2021-05-27 English
Change of Director's Interest Notice - PH 3 pages 202.2KB
Director's Dealing
2021-05-26 English
CEO & Executive Chairman increases IMU shareholding 2 pages 205.9KB
Capital/Financing Update
2021-05-24 English
Proposed issue of Securities - IMU 6 pages 29.9KB
Capital/Financing Update
2021-05-24 English
Appendix 2A 15 pages 392.4KB
Regulatory Filings
2021-05-24 English
Change of Director's Interest Notice - CW 3 pages 180.5KB
Director's Dealing
2021-05-24 English
Change of Director's Interest Notice - LC 3 pages 181.4KB
Director's Dealing
2021-05-24 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2021-05-20 English
Appendix 2A 15 pages 394.4KB
Regulatory Filings
2021-05-20 English
IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS 3 pages 147.3KB
Capital/Financing Update
2021-05-17 English
Investor Presentation 18 pages 3.3MB
Investor Presentation
2021-05-17 English
Investor Webinar Details 2 pages 98.0KB
Regulatory Filings
2021-05-17 English
Proposed issue of Securities - IMU 5 pages 27.0KB
Capital/Financing Update
2021-05-13 English
Appendix 2A 15 pages 388.0KB
Capital/Financing Update
2021-05-13 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2021-05-06 English
Appendix 2A 15 pages 394.0KB
Regulatory Filings
2021-05-06 English
Prestigious Research Journal Publish HER-Vaxx Phase 1B Data 2 pages 129.1KB
Regulatory Filings
2021-04-28 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2021-04-28 English
Appendix 2A 15 pages 393.3KB
Regulatory Filings
2021-04-28 English
Appendix 4C - quarterly 8 pages 314.5KB
Interim / Quarterly Report
2021-04-22 English
Imugene announces clinical milestone for HER-Vaxx 2 pages 130.8KB
Regulatory Filings
2021-04-20 English
Proposed issue of Securities - IMU 6 pages 29.9KB
Capital/Financing Update
2021-04-18 English
Appendix 2A 15 pages 395.5KB
Capital/Financing Update
2021-04-18 English
Imugene HER-Vaxx Presentation at AACR 2021 Meeting 3 pages 131.9KB
Investor Presentation
2021-04-11 English
Imugene Oncolytic Virus Presentation at AACR 2021 Meeting 2 pages 106.2KB
Regulatory Filings
2021-04-11 English
Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX 3 pages 130.6KB
Regulatory Filings
2021-04-06 English
Proposed issue of Securities - IMU 6 pages 29.9KB
Capital/Financing Update
2021-03-31 English
Appendix 2A 15 pages 432.6KB
Capital/Financing Update
2021-03-31 English
Appendix 3G 13 pages 367.8KB
Share Issue/Capital Change
2021-03-11 English
Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting 2 pages 128.1KB
Regulatory Filings
2021-03-10 English
Imugene to Present Oncolytic Virus Data at AACR21 Meeting 2 pages 123.7KB
Regulatory Filings
2021-03-10 English
Half Yearly Report and Accounts 36 pages 6.4MB
Interim / Quarterly Report
2021-02-25 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2021-02-22 English
Appendix 2A 15 pages 395.0KB
Capital/Financing Update
2021-02-22 English
Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX Trial 2 pages 130.5KB
Regulatory Filings
2021-02-11 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2021-02-02 English
Appendix 2A 15 pages 395.3KB
Regulatory Filings
2021-02-02 English
Appendix 4C - quarterly 8 pages 279.6KB
Interim / Quarterly Report
2021-01-28 English
Proposed issue of Securities - IMU 5 pages 28.1KB
Capital/Financing Update
2021-01-26 English
Appendix 2A 15 pages 394.9KB
Regulatory Filings
2021-01-26 English
Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial 2 pages 133.1KB
Regulatory Filings
2021-01-20 English
IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM 2 pages 105.7KB
Regulatory Filings
2021-01-06 English